Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00829166 |
|---|---|
| Brief Title: | A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer (EMILIA) |
| First Submitted : | January 22, 2009 |
| First Submitted that Met QC Criteria : | January 22, 2009 |
| First Posted : | January 26, 2009 (Estimate) |
| Results First Submitted : | February 22, 2013 |
| Results First Submitted that Met QC Criteria : | April 22, 2013 |
| Results First Posted : | April 23, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 10, 2016 |
| Last Update Posted : | October 31, 2016 (Estimate) |